EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing Tool

Tianwen Li iD, Liansheng Zhang, Tao Lu, Tongming Zhu, Canbin Feng, Ni Gao, Fei Liu, Jingyu Yu, Kezhu Chen, Junjie Zhong, Qisheng Tang, Quan Zhang und 5 weitere

Advanced Science · 2023-04 · 10 (10)

DOI: 10.1002/advs.202206517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 02.02.2023. Verfasst von Tianwen Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, National Center for Neurological Disorders, National Key La…. Hauptthemen laut MEDLINE: RNA Editing, Gene Editing. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Science, Ministry of Science and Technology of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Engineered extracellular vesicles (EVs) are considered excellent delivery vehicles for a variety of therapeutic agents, including nucleic acids, proteins, drugs, and nanomaterials. Recently, several studies have indicated that clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated 9 (Cas9) delivered by EVs enable efficient DNA editing. However, an RNA editing tool delivered by EVs is still unavailable. Here, a signal peptide‐optimized and EVs‐delivered guide RNA (gRNA) and CRISPR/CasRx (Cas13d) system capable of rapidly inhibiting the expression of targeted genes with quick catabolism after performing their functions is developed. EVs with CRISPR/CasRx and tandem gRNAs targeting pivotal cytokines are further packed whose levels increase substantially over the course of acute inflammatory diseases and find that these engineered EVs inhibit macrophage activation in vitro. More importantly, this system attenuates lipopolysaccharide (LPS)‐triggered acute lung injury and sepsis in the acute phase, mitigating organ damage and improving the prognosis in vivo. In summary, a potent tool is provided for short‐acting RNA editing, which could be a powerful therapeutic platform for the treatment of acute diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA EditingGene EditingRNA, Guide, CRISPR-Cas Systems

Stichwörter der Autor:innen

CRISPR/CasRxRNA editingextracellular vesiclesinflammatory disease

Substanzen

RNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, National Center for Neurological Disorders, National Key Laboratory for Medical Neurobiology, Institutes of Brain Science, Shangh…
  • Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai Research Center for Brain Science…
  • Anhui Province Key Laboratory of Clinical and Preclinical Research in Respiratory Disease, Molecular Diagnosis Center, Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Bengbu Medical Colleg…

ORCID-Profile: Tianwen Li

Förderung

  • Chinese Academy of Science
  • Ministry of Science and Technology of China
  • National Natural Science Foundation of China
  • Shanghai Municipal Government
  • Peak Disciplines (Type IV) of Institutions of Higher Leaning in Shanghai

Zitieren

APA

Li, T., Zhang, L., Lu, T., Zhu, T., Feng, C., Gao, N., Liu, F., Yu, J., Chen, K., Zhong, J., Tang, Q., Zhang, Q., Deng, X., Ren, J., Zeng, J., Zhou, H., & Zhu, J. (2023). Engineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing Tool. Advanced Science, 10(10). https://doi.org/10.1002/advs.202206517

Vancouver

Li T, Zhang L, Lu T, Zhu T, Feng C, Gao N, et al. Engineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing Tool. Advanced Science. 2023;10(10). doi:10.1002/advs.202206517

BibTeX
@article{Li2023,
  author = {Li, Tianwen and Zhang, Liansheng and Lu, Tao and Zhu, Tongming and Feng, Canbin and Gao, Ni and Liu, Fei and Yu, Jingyu and Chen, Kezhu and Zhong, Junjie and Tang, Qisheng and Zhang, Quan and Deng, Xiangyang and Ren, Junwei and Zeng, Jun and Zhou, Haibo and Zhu, Jianhong},
  title = {Engineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing Tool},
  journal = {Advanced Science},
  year = {2023},
  volume = {10},
  number = {10},
  doi = {10.1002/advs.202206517}
}
Kostenlos starten →